Safe Haven Defense Appoints Rudy Diaz as Chief Executive Officer
SCOTTSDALE, Ariz., June 12, 2025 /PRNewswire/ -- Safe Haven Defense US, LLC ("Safe Haven Defense"), a premier provider of branded, proprietary window security laminate systems in North America, has announced the appointment of Rodolfo "Rudy" Diaz as Chief Executive Officer, effective June 12th. Cameron Evans will step down from his role as interim CEO and will remain actively involved as a member of the Board of Directors.
"I am confident that Rudy's leadership and deep experience in the security industry will help drive continued growth and success for Safe Haven Defense," said Evans.
Rudy brings over three decades of leadership experience in security, risk management, and compliance. Most recently, he served as President of Gordian Risk Solutions, a firm he founded to help multinational organizations navigate complex security and operational challenges. His background includes senior leadership roles at Iron Mountain, Flex LTD, Allied Universal, SOS Security, Hewlett Packard, and GlobalFoundries. Throughout his career, Rudy has safeguarded human capital, physical assets, supply chains, and intellectual property of various enterprises across the globe. His work has supported a wide array of industries including Government, Consumer, Automotive, Technology, Healthcare, Financial, Entertainment, and Critical Infrastructure sectors. A Marquette University graduate with a BA in Criminology, Rudy is also a U.S. Marine Corps combat veteran, twice awarded the Bronze Star with "V" for valor.
"I am honored to join Safe Haven Defense and look forward to advancing the Company's national expansion and strengthening partnerships across commercial and institutional markets," said Diaz. "I'm especially excited to continue the Company's mission to protect people and assets with innovative, effective, and high-impact security solutions."
"We look forward to having Rudy on board to help guide Safe Haven Defense through its continued growth as the market leader in the security window laminate system market," said Steve Johnson, Founder and President of Safe Haven Defense.
About Safe Haven Defense:Based in Scottsdale, AZ, Safe Haven Defense is the premier provider of branded, proprietary window security laminate solutions across North America. The company delivers cost-effective, security laminate certified by third-party accredited laboratories. Applied on-site to existing windows with minimal disruption, the film enhances protection against ballistic, forced entry, explosions, and severe weather threats. Safe Haven Defense serves a wide range of sectors including education, commercial, retail, government, and healthcare, with installations completed in over 1,000 facilities across all 50 states.
For more information, please visit: safehavendefense.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/safe-haven-defense-appoints-rudy-diaz-as-chief-executive-officer-302480418.html
SOURCE Safe Haven Defense US, LLC
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
39 minutes ago
- Business Wire
CARMAT Announces Filing Today for Insolvency and Requesting Being Placed in Receivership
PARIS--(BUSINESS WIRE)--Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world's most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from advanced biventricular heart failure (the ' Company ' or ' CARMAT '), today announces filing for insolvency 1 and requesting to be placed in receivership 2 to the Versailles Economic Affairs Court 3, as well as the suspension of CARMAT shares trading, starting June 30, 2025, before stock market opening. Insolvency filing and request to be placed in receivership On June 20, 2025, CARMAT announced in a press release being at risk of insolvency as early as the end of June 2025 unless managing before then, to secure additional cash of at least €3.5 million. Despite its continued efforts, the Company has not managed at this stage, to secure neither additional cash nor new financing. Given this, the Company will today file for insolvency and request to be placed in receivership to the Versailles Economic Affairs Court ('the Court'). The Court will rule on this request, following a hearing expected in the coming days. As a reminder, according to its current business plan and assuming 'business as usual' situation, the Company estimates its funding requirements over the next 12 months at approximately €35 million, including approximately €20 million by the end of December 2025. Suspension of CARMAT shares trading (ISIN code: FR0010907956, Ticker: ALCAR) Pending the Court's decision, CARMAT has asked Euronext to suspend the trading of its shares starting on June 30, 2025, before the stock market opens. The Company anticipates this suspension to be lifted once the Court's decision has been rendered and communicated to the market. Next steps Pending the Court's decision, CARMATS's operations carry-on and the Company continues to actively explore all options to ensure the continuation of its business activities. The Company believes that the opening of a receivership procedure would be the most appropriate framework to facilitate this continuation. More generally, whatever the Court's decision, the Company will endeavor to provide continuous support to patients who currently benefit from its Aeson® artificial heart. Press releases will be issued regularly as the Company's situation evolves and the proceedings progress. About CARMAT CARMAT is a French MedTech that designs, manufactures and markets the Aeson ® artificial heart. The Company's ambition is to make Aeson ® the first alternative to a heart transplant, and thus provide a therapeutic solution to people suffering from end-stage biventricular heart failure, who are facing a well-known shortfall in available human grafts. The world's first physiological artificial heart that is highly hemocompatible, pulsatile and self-regulated, Aeson ® could save, every year, the lives of thousands of patients waiting for a heart transplant. The device offers patients quality of life and mobility thanks to its ergonomic and portable external power supply system that is continuously connected to the implanted prosthesis. Aeson ® is commercially available as a bridge to transplant in the European Union and other countries that recognize CE marking. Aeson ® is also currently being assessed within the framework of an Early Feasibility Study (EFS) in the United States. Founded in 2008, CARMAT is based in the Paris region, with its head offices located in Vélizy-Villacoublay and its production site in Bois-d'Arcy. The Company can rely on the talent and expertise of a multidisciplinary team of circa 200 highly specialized people. CARMAT is listed on the Euronext Growth market in Paris (Ticker: ALCAR / ISIN code: FR0010907956). For more information, please go to and follow us on LinkedIn. Disclaimer This press release and the information it contains do not constitute an offer to sell or subscribe, nor a solicitation of an offer to buy or subscribe, for CARMAT shares in any country. This press release may contain forward-looking statements regarding the Company's objectives and outlook. These forward-looking statements are based on the current estimates and anticipations of the Company's management and are subject to risk factors and uncertainties, including those described in its Universal Registration Document filed with the French Financial Markets Authority (Autorité des marchés financiers) (the 'AMF') under number D.25-0345 (the ' 2024 Universal Registration Document '), available free of charge on the websites of CARMAT ( and the AMF ( Readers' attention is particularly drawn to the fact that the Company's current cash runway extends only until the end of June 2025, and that CARMAT is therefore facing a very high risk of default, including in the very short term. The Company is also exposed to other risks and uncertainties, such as its ability to implement its strategy, the pace of development of its production and sales, the progress and results of ongoing or planned clinical trials, technological developments, the competitive landscape, regulatory changes, industrial risks, and all risks related to the management of the Company's growth. Forward-looking statements mentioned in this press release may not be achieved due to these factors or other unknown risks and uncertainties, or risks that the Company does not currently consider to be material or specific. Aeson® is an active implantable medical device commercially available in the European Union and other countries recognising the CE mark. The Aeson® total artificial heart is intended to replace the ventricles of the native heart and is indicated as a bridge to transplant in patients with end-stage biventricular heart failure (Intermacs classes 1-4) who cannot benefit from maximal medical therapy or a left ventricular assist device (LVAD) and who are likely to benefit from a heart transplant within 180 days of implantation. The decision to implant and the surgical procedure must be carried out by healthcare professionals trained by the manufacturer. The documentation (clinician's manual, patient's manual and alarm booklet) must be read carefully to learn about the characteristics of Aeson® and the information required for patient selection and proper use (contraindications, precautions, side effects) of Aeson®. In the United States, Aeson® is currently only available as part of a feasibility clinical trial approved by the Food & Drug Administration (FDA).
Miami Herald
14 hours ago
- Miami Herald
McCormick CEO warns about harsh decision amid tariff threats
Imagine cooking a meal without seasonings and forcing yourself to eat plain foods to survive because purchasing condiments has become too expensive. Not only would this rob us of the enjoyment of eating, but it would also prevent us from trying new flavors from other cultures. Don't miss the move: Subscribe to TheStreet's free daily newsletter After taking office for a second term, President Donald Trump implemented new tariffs on foreign-made imports in April, including an additional 10% baseline tariff. This has resulted in ongoing negotiations between foreign countries and the U.S., temporarily pausing increased tariffs on imported goods. Related: When you'll see empty retail store shelves due to tariffs However, the clock is ticking, and the 90-day suspension of baseline tariffs expires on July 9. Although some countries have reached agreements, others have yet to come to a mutual understanding. This threatens the supply chain of many products, which may lead to price increases. Companies have been strategizing and reorganizing their businesses, hoping to soften or prevent the potential blow tariffs might have on their finances. However, many remain concerned about negative financial repercussions, especially in sectors highly dependent on imported goods. Related: This might deliver the economy news people want to hear McCormick & Company (MKC) is a leading manufacturer, marketer, and distributor of spices, seasoning mixes, condiments, and extracts worldwide. After 136 years in business, the company has grown a portfolio of around 17,000 materials from over 90 countries. Although an American company, McCormick depends on foreign goods. Many of its products are not commercially available in the U.S. due to factors such as geographic location and climate. The new tariffs have hit the decades-old business like a train, leading McCormick to reveal plans that American consumers had been dreading. McCormick said it will raise prices during the fourth fiscal quarter of 2025, as the costs of certain products will be higher than expected. "Our total gross annualized tariff exposure is approximately $90,000,000 and in terms of 2025 in year exposure, it's about $50,000,000," said McCormick CEO Brendan Foley in the company's latest earnings call. More Retail News: Popular grocery store chain resumes store openings after 3-year hiatusHershey adds new products to move beyond chocolateBankrupt retail chain makes major comeback, reopens new stores However, the company will continue to look for lower-cost sourcing alternatives to keep up with demand and mitigate the tariff effects. McCormick understands that price hikes could decrease sales, as it would prompt consumers to seek cheaper options. "We are collaborating with our customers to implement surgical and strategic pricing, while also maintaining our volume momentum," said Foley. "Overall, our manufacturing location strategy, resilient supply chain, global sourcing capabilities, collaborative efforts across the organization and the strength of our brands continue to be a competitive advantage, enabling us to mitigate our costs and maintain our business momentum." Although McCormick has focused on decreasing its reliance on any one geographic area, Foley still warned that many products cannot be substituted because they aren't produced or available in the U.S. Related: Veteran fund manager unveils eye-popping S&P 500 forecast The Arena Media Brands, LLC THESTREET is a registered trademark of TheStreet, Inc.
Business Wire
2 days ago
- Business Wire
Rocket Lab Completes Record Launch Turnaround From Launch Complex 1, Successfully Deploys 68 th Electron Mission
MAHIA, New Zealand--(BUSINESS WIRE)--Rocket Lab Corporation (Nasdaq: RKLB) ('Rocket Lab' or 'the Company'), a global leader in launch services and space systems, today successfully launched its 68th Electron rocket to deploy a single satellite to space for a confidential commercial customer. The mission was the second of two launches from the same launch site in less than 48 hours, a new launch record for the Company as it continues to deliver dedicated, repeatable and reliable access to space for satellite operators. The 'Symphony In The Stars' mission lifted-off from Rocket Lab Launch Complex 1 in Mahia, New Zealand on June 28 th (7:08 p.m./07:08 UTC) to deploy a single spacecraft to a 650km circular Earth orbit. The mission was the first of two dedicated launches for the new customer on Electron booked less than four months ago, with a second mission scheduled before the end of 2025. Rocket Lab has now completed four launches in June for commercial satellite constellation operators, underscoring Electron's consistent performance and rapid deployment capabilities as the world's leading small launcher: the 'Full Stream Ahead' mission on June 3 rd; 'The Mountain God Guards' mission on June 11 th; 'Get The Hawk Outta Here' launched on June 26 th UTC, and today's 'Symphony In The Stars' mission. Rocket Lab Founder and CEO, Sir Peter Beck, says: 'Electron has demonstrated once again that it is the gold standard for responsive and reliable space access for small satellites. The future of space is built on proven performance, and Electron continues to deliver against a stacked launch manifest this year. Congratulations to the team on achieving its fastest launch turnaround yet between two missions from Launch Complex 1. This launch was also a quick-turn mission to meet our customer's mission requirements, and we're looking forward to doing it again later this year.' 'Symphony In The Stars' was Rocket Lab's tenth Electron mission of 2025 and its 68th launch overall. With 100% mission success so far this year, Electron continues to deliver reliable deployment amid an increasing launch cadence and rapid contract-to-launch timelines. Launch images: About Rocket Lab Founded in 2006, Rocket Lab is an end-to-end space company with an established track record of mission success. We deliver reliable launch services, satellite manufacture, spacecraft components, and on-orbit management solutions that make it faster, easier, and more affordable to access space. Headquartered in Long Beach, California, Rocket Lab designs and manufactures the Electron small orbital launch vehicle, a family of spacecraft platforms, and the Company is developing the large Neutron launch vehicle for constellation deployment. Since its first orbital launch in January 2018, Rocket Lab's Electron launch vehicle has become the second most frequently launched U.S. rocket annually and has delivered over 200 satellites to orbit for private and public sector organizations, enabling operations in national security, scientific research, space debris mitigation, Earth observation, climate monitoring, and communications. Rocket Lab's spacecraft platforms have been selected to support NASA missions to the Moon and Mars, as well as the first private commercial mission to Venus. Rocket Lab has three launch pads at two launch sites, including two launch pads at a private orbital launch site located in New Zealand and a third launch pad in Virginia. Forward Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward looking statements contained in Section 27A of the Securities Act of 1933, as amended (the 'Securities Act') and Section 21E of the Securities Exchange Act of 1934, as amended (the 'Exchange Act'). All statements contained in this press release other than statements of historical fact, including, without limitation, statements regarding our launch and space systems operations, launch schedule and window, safe and repeatable access to space, Neutron development, operational expansion and business strategy are forward-looking statements. The words 'believe,' 'may,' 'will,' 'estimate,' 'potential,' 'continue,' 'anticipate,' 'intend,' 'expect,' 'strategy,' 'future,' 'could,' 'would,' 'project,' 'plan,' 'target,' and similar expressions are intended to identify forward-looking statements, though not all forward-looking statements use these words or expressions. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including but not limited to the factors, risks and uncertainties included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, as such factors may be updated from time to time in our other filings with the Securities and Exchange Commission (the 'SEC'), accessible on the SEC's website at and the Investor Relations section of our website at which could cause our actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management's estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change.
